News Releases

Highlights: Completed two strategic acquisitions in China Full year 2009 cash flow from operations of $253 million Establishing strategic outsourcing partnerships Planning to spin off compound partnering business by mid-2010 WILMINGTON, N.C....

WILMINGTON, N.C. (January 25, 2010) - PPD, Inc. (Nasdaq: PPDI) will release its fourth quarter and full-year 2009 financial results on Monday, February 8, 2010, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com. On Tuesday, February 9, 2010,...

WILMINGTON, N.C. (December 22, 2009) - PPD, Inc. (Nasdaq: PPDI) will release its fiscal year 2010 financial guidance on Tuesday, January 19, 2010, after the market closes. The release will be available on the PPD Web site at http://www.ppdi.com. On Wednesday, January 20, 2010, at 9 a.m. EST, PPD ...

WILMINGTON, N.C. (December 2, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data. The biostatistics technology infrastructure (BTI) is a centralized computing platform that enhances the company's ability to deliver secure, qu...

WILMINGTON, N.C. (November 18, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand PPD's drug development capabilities in China.   ...

WILMINGTON, N.C. (November 11, 2009) -- PPD, Inc. (Nasdaq: PPDI) today announced its board of directors declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the fourth quarter dividend is December 15, 2009, and the payment...

WILMINGTON, N.C. (November 6, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China. The acquisition strengthens PPD's full range of drug development services in the country and positions it to capita...

WILMINGTON, N.C. (October 27, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has been awarded a contract by the U.S. Food and Drug Administration (FDA) to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. The company will conduct a thorough evaluation of th...

WILMINGTON, N.C. (October 27, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has entered into an agreement to acquire Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China, providing PPD additional capacity and expertise in this rapidly gro...

WILMINGTON, N.C. (October 21, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced Sandra Luikenhuis, Ph.D., executive director of PPD® Dermatology, will present at the 2009 Boston Biotech R&D Conference in Boston, Mass., where she will introduce PPD Dermatology ...